Overview

Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The study investigates the safety and efficacy of PMX-30063 in patients treated for acute bacterial skin and skin-structure infection (ABSSSI).
Phase:
Phase 2
Details
Lead Sponsor:
PolyMedix, Inc.
Treatments:
Daptomycin